Zhou M, Xu Y, Zhang L, Yang Y, Zheng J
Front Cardiovasc Med. 2025; 12:1499065.
PMID: 40066352
PMC: 11891352.
DOI: 10.3389/fcvm.2025.1499065.
Lotfinaghsh A, Imam A, Pompian A, Stitziel N, Javaheri A
Curr Heart Fail Rep. 2025; 22(1):12.
PMID: 40063168
DOI: 10.1007/s11897-025-00698-w.
Maxwell C, Bhakta N, Denniff M, Sandhu J, Kessler T, Ng L
J Mol Cell Cardiol Plus. 2025; 11:100283.
PMID: 39895831
PMC: 11782998.
DOI: 10.1016/j.jmccpl.2025.100283.
Osawa I, Akita K, Hasegawa K, Fifer M, Tower-Rader A, Reilly M
Circ Heart Fail. 2025; 18(2):e012343.
PMID: 39831317
PMC: 11835532.
DOI: 10.1161/CIRCHEARTFAILURE.124.012343.
Patel-Murray N, Zhang L, Claggett B, Xu D, Serrano-Fernandez P, Healey M
J Am Heart Assoc. 2024; 13(13):e033544.
PMID: 38904251
PMC: 11255700.
DOI: 10.1161/JAHA.123.033544.
Using Omics to Identify Novel Therapeutic Targets in Heart Failure.
Lteif C, Huang Y, Guerra L, Gawronski B, Duarte J
Circ Genom Precis Med. 2024; 17(3):e004398.
PMID: 38766848
PMC: 11187651.
DOI: 10.1161/CIRCGEN.123.004398.
Incident heart failure in chronic kidney disease: proteomics informs biology and risk stratification.
Dubin R, Deo R, Ren Y, Wang J, Pico A, Mychaleckyj J
Eur Heart J. 2024; 45(30):2752-2767.
PMID: 38757788
PMC: 11313584.
DOI: 10.1093/eurheartj/ehae288.
Incremental Value of a Metabolic Risk Score for Heart Failure Mortality: A Population-Based Study.
Joo J, Shearer J, Wolska A, Remaley A, Otvos J, Connelly M
Circ Genom Precis Med. 2024; 17(2):e004312.
PMID: 38516784
PMC: 11021175.
DOI: 10.1161/CIRCGEN.123.004312.
Proteomic Associations of Adverse Outcomes in Human Heart Failure.
Dib M, Levin M, Zhao L, Diab A, Wang Z, Ebert C
J Am Heart Assoc. 2024; 13(5):e031154.
PMID: 38420755
PMC: 10944037.
DOI: 10.1161/JAHA.123.031154.
Ongoing Enigma of NT-proBNP in HFpEF: Insights From Proteomics.
Myhre P, Omland T, Shah A
Circ Heart Fail. 2024; 17(2):e011428.
PMID: 38299326
PMC: 10963043.
DOI: 10.1161/CIRCHEARTFAILURE.123.011428.
Proteomics for heart failure risk stratification: a systematic review.
Kuku K, Oyetoro R, Hashemian M, Livinski A, Shearer J, Joo J
BMC Med. 2024; 22(1):34.
PMID: 38273315
PMC: 10809595.
DOI: 10.1186/s12916-024-03249-7.
Large scale plasma proteomics identifies novel proteins and protein networks associated with heart failure development.
Shah A, Myhre P, Arthur V, Dorbala P, Rasheed H, Buckley L
Nat Commun. 2024; 15(1):528.
PMID: 38225249
PMC: 10789789.
DOI: 10.1038/s41467-023-44680-3.
Development and Validation of a Protein Risk Score for Mortality in Heart Failure : A Community Cohort Study.
Kuku K, Shearer J, Hashemian M, Oyetoro R, Park H, Dulek B
Ann Intern Med. 2024; 177(1):39-49.
PMID: 38163367
PMC: 10958437.
DOI: 10.7326/M23-2328.
Effects of IL-1β inhibition on anemia and clonal hematopoiesis in the randomized CANTOS trial.
Woo J, Lu D, Lewandowski A, Xu H, Serrano P, Healey M
Blood Adv. 2023; 7(24):7471-7484.
PMID: 37934948
PMC: 10758744.
DOI: 10.1182/bloodadvances.2023011578.
Recent successes in heart failure treatment.
Lam C, Docherty K, Ho J, McMurray J, Myhre P, Omland T
Nat Med. 2023; 29(10):2424-2437.
PMID: 37814060
DOI: 10.1038/s41591-023-02567-2.
The emerging Janus face of SVEP1 in development and disease.
Elenbaas J, Jung I, Coler-Reilly A, Lee P, Alisio A, Stitziel N
Trends Mol Med. 2023; 29(11):939-950.
PMID: 37673700
PMC: 10592172.
DOI: 10.1016/j.molmed.2023.08.002.
High-Throughput CSF Proteomics and Machine Learning to Identify Proteomic Signatures for Parkinson Disease Development and Progression.
Tsukita K, Sakamaki-Tsukita H, Kaiser S, Zhang L, Messa M, Serrano-Fernandez P
Neurology. 2023; 101(14):e1434-e1447.
PMID: 37586882
PMC: 10573147.
DOI: 10.1212/WNL.0000000000207725.
